# ANAVEX LIFE SCIENCES CORP. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:121f7b6f-a4b4-45f7-98f2-23c1a8e32884 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/anavex-life-sciences-corp | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 24 | | Claims under review | 1 | | Evidence records | 5 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-19T14:44:56.273334+00:00 | | Last reviewed | 2026-10-19T14:44:56.273334+00:00 | ## Identity - Legal name: ANAVEX LIFE SCIENCES CORP. - Display name: ANAVEX LIFE SCIENCES CORP. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-20T04:38:05.479795+00:00 | | Completeness | 0.409 | | Record Quality | 0.832 | | Directors | 6 | | Committees | 6 | | Governance events | 14 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Athanasios Skarpelos: Director. Status: current. Independent: true. Since: 2013-01-01. claim_id=alpha:claim:company:121f7b6f-a4b4-45f7-98f2-23c1a8e32884:leadership_role:5 - Christopher Missling, PhD: Director. Status: current. Independent: false. Since: 2013-01-01. claim_id=alpha:claim:company:121f7b6f-a4b4-45f7-98f2-23c1a8e32884:leadership_role:6 - Claus van der Velden, PhD: Director. Status: current. Independent: true. Since: 2018-01-01. Committees: Audit (chair); Audit · Chair; Compensation · Chair; Nominating and Governance · Chair (member); Compensation (chair); Nominating and Governance (chair). claim_id=alpha:claim:company:121f7b6f-a4b4-45f7-98f2-23c1a8e32884:leadership_role:7 - Jiong Ma, PhD: Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Audit (member); Audit; Compensation · Chair; Nominating and Governance (member); Compensation (chair); Nominating and Governance (member). claim_id=alpha:claim:company:121f7b6f-a4b4-45f7-98f2-23c1a8e32884:leadership_role:8 - Peter Donhauser, D.O.: Director. Status: current. Independent: true. Since: 2017-01-01. claim_id=alpha:claim:company:121f7b6f-a4b4-45f7-98f2-23c1a8e32884:leadership_role:9 - Steffen Thomas, PhD: Director. Status: current. Independent: true. Since: 2015-01-01. Committees: Audit (member); Audit; Compensation; Nominating and Governance (member); Compensation (member); Nominating and Governance (member). claim_id=alpha:claim:company:121f7b6f-a4b4-45f7-98f2-23c1a8e32884:leadership_role:10 ## Committees - Audit (audit). Chair: Claus van der Velden, PhD. Members: Claus van der Velden, PhD (chair, current); Jiong Ma, PhD (member, current); Steffen Thomas, PhD (member, current). committee_id=alpha:committee:anavex-life-sciences-corp:audit - Audit · Chair; Compensation · Chair; Nominating and Governance · Chair (audit). Chair: NOT_PUBLISHED. Members: Claus van der Velden, PhD (member, current). committee_id=alpha:committee:anavex-life-sciences-corp:audit-chair-compensation-chair-nominating-and-governance-chair - Audit; Compensation · Chair; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: Jiong Ma, PhD (member, current). committee_id=alpha:committee:anavex-life-sciences-corp:audit-compensation-chair-nominating-and-governance - Audit; Compensation; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: Steffen Thomas, PhD (member, current). committee_id=alpha:committee:anavex-life-sciences-corp:audit-compensation-nominating-and-governance - Compensation (compensation). Chair: Jiong Ma, PhD. Members: Claus van der Velden, PhD (chair, current); Jiong Ma, PhD (chair, current); Steffen Thomas, PhD (member, current). committee_id=alpha:committee:anavex-life-sciences-corp:compensation - Nominating and Governance (nominating_governance). Chair: Claus van der Velden, PhD. Members: Claus van der Velden, PhD (chair, current); Jiong Ma, PhD (member, current); Steffen Thomas, PhD (member, current). committee_id=alpha:committee:anavex-life-sciences-corp:nominating-and-governance ## Executive leadership - Christopher Missling: Chief Executive Officer (Principal Executive Officer) and Director [CEO]. Status: current. claim_id=alpha:claim:company:121f7b6f-a4b4-45f7-98f2-23c1a8e32884:leadership_role:11 - Sandra Boenisch: Principal Financial Officer and Treasurer (Principal Accounting Officer). Status: current. claim_id=alpha:claim:company:121f7b6f-a4b4-45f7-98f2-23c1a8e32884:leadership_role:12 ## Governance events - CEO_CHANGED: Christopher Missling executive of ANAVEX LIFE SCIENCES CORP., effective 2025-11-25. Effective: 2025-11-25. Detected: 2026-10-19T14:44:56.273334+00:00. event_id=alpha:event:transition:mbpqskqioo8a - EXECUTIVE_APPOINTED: Sandra Boenisch executive of ANAVEX LIFE SCIENCES CORP., effective 2025-11-25. Effective: 2025-11-25. Detected: 2026-10-19T14:44:56.273334+00:00. event_id=alpha:event:transition:mgg0v91v2gi2p - DIRECTOR_APPOINTED: Jiong Ma, PhD seat on ANAVEX LIFE SCIENCES CORP., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-19T14:44:56.273334+00:00. event_id=alpha:event:transition:e94lhg5kpfta - COMMITTEE_CREATED: Audit; Compensation · Chair; Nominating and Governance committee of ANAVEX LIFE SCIENCES CORP., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-19T14:44:56.273334+00:00. event_id=alpha:event:transition:1s66g54gy283i - COMMITTEE_MEMBER_ADDED: Jiong Ma, PhD member of Audit; Compensation · Chair; Nominating and Governance, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-19T14:44:56.273334+00:00. event_id=alpha:event:transition:xfz0yadvn2vi - DIRECTOR_APPOINTED: Claus van der Velden, PhD seat on ANAVEX LIFE SCIENCES CORP., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-19T14:44:56.273334+00:00. event_id=alpha:event:transition:hjtm711ey3mpv - COMMITTEE_CREATED: Audit · Chair; Compensation · Chair; Nominating and Governance · Chair committee of ANAVEX LIFE SCIENCES CORP., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-19T14:44:56.273334+00:00. event_id=alpha:event:transition:uwecincz50nz - COMMITTEE_MEMBER_ADDED: Claus van der Velden, PhD member of Audit · Chair; Compensation · Chair; Nominating and Governance · Chair, effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-19T14:44:56.273334+00:00. event_id=alpha:event:transition:parrq31fo1qvv - DIRECTOR_APPOINTED: Peter Donhauser, D.O. seat on ANAVEX LIFE SCIENCES CORP., effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-19T14:44:56.273334+00:00. event_id=alpha:event:transition:1kkw1181eah2aa - DIRECTOR_APPOINTED: Steffen Thomas, PhD seat on ANAVEX LIFE SCIENCES CORP., effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-19T14:44:56.273334+00:00. event_id=alpha:event:transition:1n3p65i1mbl5m8 - COMMITTEE_CREATED: Audit; Compensation; Nominating and Governance committee of ANAVEX LIFE SCIENCES CORP., effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-19T14:44:56.273334+00:00. event_id=alpha:event:transition:ziwapm1ay9csw - COMMITTEE_MEMBER_ADDED: Steffen Thomas, PhD member of Audit; Compensation; Nominating and Governance, effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-19T14:44:56.273334+00:00. event_id=alpha:event:transition:p6ygr6cu1tpk - DIRECTOR_APPOINTED: Athanasios Skarpelos seat on ANAVEX LIFE SCIENCES CORP., effective 2013-01-01. Effective: 2013-01-01. Detected: 2026-10-19T14:44:56.273334+00:00. event_id=alpha:event:transition:140fzakr8ix42 - DIRECTOR_APPOINTED: Christopher Missling, PhD seat on ANAVEX LIFE SCIENCES CORP., effective 2013-01-01. Effective: 2013-01-01. Detected: 2026-10-19T14:44:56.273334+00:00. event_id=alpha:event:transition:1aei3ix1ixlrqd ## Scoped resources - `alpha://company/anavex-life-sciences-corp` (contract): https://registry.alpha.ac/api/public/companies/anavex-life-sciences-corp?format=record - `alpha://company/anavex-life-sciences-corp/identity` (contract): https://registry.alpha.ac/api/public/companies/anavex-life-sciences-corp?format=record§ion=identity - `alpha://company/anavex-life-sciences-corp/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/anavex-life-sciences-corp?format=record§ion=corporate-structure - `alpha://company/anavex-life-sciences-corp/board` (contract): https://registry.alpha.ac/api/public/companies/anavex-life-sciences-corp?format=record§ion=board - `alpha://company/anavex-life-sciences-corp/committees` (contract): https://registry.alpha.ac/api/public/companies/anavex-life-sciences-corp?format=record§ion=committees - `alpha://company/anavex-life-sciences-corp/leadership` (contract): https://registry.alpha.ac/api/public/companies/anavex-life-sciences-corp?format=record§ion=leadership - `alpha://company/anavex-life-sciences-corp/ownership` (contract): https://registry.alpha.ac/api/public/companies/anavex-life-sciences-corp?format=record§ion=ownership - `alpha://company/anavex-life-sciences-corp/financials` (contract): https://registry.alpha.ac/api/public/companies/anavex-life-sciences-corp?format=record§ion=financials - `alpha://company/anavex-life-sciences-corp/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/anavex-life-sciences-corp?format=record§ion=capital-structure - `alpha://company/anavex-life-sciences-corp/compensation` (contract): https://registry.alpha.ac/api/public/companies/anavex-life-sciences-corp?format=record§ion=compensation - `alpha://company/anavex-life-sciences-corp/governance` (contract): https://registry.alpha.ac/api/public/companies/anavex-life-sciences-corp?format=record§ion=governance - `alpha://company/anavex-life-sciences-corp/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/anavex-life-sciences-corp?format=record§ion=shareholder-governance - `alpha://company/anavex-life-sciences-corp/audit` (contract): https://registry.alpha.ac/api/public/companies/anavex-life-sciences-corp?format=record§ion=audit - `alpha://company/anavex-life-sciences-corp/legal` (contract): https://registry.alpha.ac/api/public/companies/anavex-life-sciences-corp?format=record§ion=legal - `alpha://company/anavex-life-sciences-corp/risk` (contract): https://registry.alpha.ac/api/public/companies/anavex-life-sciences-corp?format=record§ion=risk - `alpha://company/anavex-life-sciences-corp/cyber` (contract): https://registry.alpha.ac/api/public/companies/anavex-life-sciences-corp?format=record§ion=cyber - `alpha://company/anavex-life-sciences-corp/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/anavex-life-sciences-corp?format=record§ion=ai-governance - `alpha://company/anavex-life-sciences-corp/agents` (contract): https://registry.alpha.ac/api/public/companies/anavex-life-sciences-corp?format=record§ion=agents - `alpha://company/anavex-life-sciences-corp/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/anavex-life-sciences-corp?format=record§ion=ecosystem - `alpha://company/anavex-life-sciences-corp/events` (contract): https://registry.alpha.ac/api/public/companies/anavex-life-sciences-corp?format=record§ion=events - `alpha://company/anavex-life-sciences-corp/relationships` (contract): https://registry.alpha.ac/api/public/companies/anavex-life-sciences-corp?format=record§ion=relationships - `alpha://company/anavex-life-sciences-corp/assessments` (contract): https://registry.alpha.ac/api/public/companies/anavex-life-sciences-corp?format=record§ion=assessments - `alpha://company/anavex-life-sciences-corp/evidence` (contract): https://registry.alpha.ac/api/public/companies/anavex-life-sciences-corp?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:121f7b6f-a4b4-45f7-98f2-23c1a8e32884:committee_appointment:14: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:claus-van-der-velden-phd","name":"Claus van der Velden, PhD"},"source_id":"board_seats"}` - Claim alpha:claim:company:121f7b6f-a4b4-45f7-98f2-23c1a8e32884:committee_appointment:15: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:jiong-ma-phd","name":"Jiong Ma, PhD"},"source_id":"board_seats"}` - Claim alpha:claim:company:121f7b6f-a4b4-45f7-98f2-23c1a8e32884:committee_appointment:16: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:steffen-thomas-phd","name":"Steffen Thomas, PhD"},"source_id":"board_seats"}` - Claim alpha:claim:company:121f7b6f-a4b4-45f7-98f2-23c1a8e32884:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:claus-van-der-velden-phd","name":"Claus van der Velden, PhD"},"source_id":"board_seats"}` - Claim alpha:claim:company:121f7b6f-a4b4-45f7-98f2-23c1a8e32884:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:jiong-ma-phd","name":"Jiong Ma, PhD"},"source_id":"board_seats"}` - Claim alpha:claim:company:121f7b6f-a4b4-45f7-98f2-23c1a8e32884:committee_appointment:20: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:steffen-thomas-phd","name":"Steffen Thomas, PhD"},"source_id":"board_seats"}` - Claim alpha:claim:company:121f7b6f-a4b4-45f7-98f2-23c1a8e32884:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:claus-van-der-velden-phd","name":"Claus van der Velden, PhD"},"source_id":"board_seats"}` - Claim alpha:claim:company:121f7b6f-a4b4-45f7-98f2-23c1a8e32884:committee_appointment:23: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:jiong-ma-phd","name":"Jiong Ma, PhD"},"source_id":"board_seats"}` - Claim alpha:claim:company:121f7b6f-a4b4-45f7-98f2-23c1a8e32884:committee_appointment:24: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:steffen-thomas-phd","name":"Steffen Thomas, PhD"},"source_id":"board_seats"}` ## Leadership - Athanasios Skarpelos: Director. Claim: alpha:claim:company:121f7b6f-a4b4-45f7-98f2-23c1a8e32884:leadership_role:5. Valid from: 2013-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:53cdf6e9a35daf9ba63df37b6f83579fbc29c895d978ced952a98aba4990fa1d. - Christopher Missling, PhD: Director. Claim: alpha:claim:company:121f7b6f-a4b4-45f7-98f2-23c1a8e32884:leadership_role:6. Valid from: 2013-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:53cdf6e9a35daf9ba63df37b6f83579fbc29c895d978ced952a98aba4990fa1d. - Claus van der Velden, PhD: Director, Audit · Chair; Compensation · Chair; Nominating and Governance · Chair. Claim: alpha:claim:company:121f7b6f-a4b4-45f7-98f2-23c1a8e32884:leadership_role:7. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:53cdf6e9a35daf9ba63df37b6f83579fbc29c895d978ced952a98aba4990fa1d. - Jiong Ma, PhD: Director, Audit; Compensation · Chair; Nominating and Governance. Claim: alpha:claim:company:121f7b6f-a4b4-45f7-98f2-23c1a8e32884:leadership_role:8. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:53cdf6e9a35daf9ba63df37b6f83579fbc29c895d978ced952a98aba4990fa1d. - Peter Donhauser, D.O.: Director. Claim: alpha:claim:company:121f7b6f-a4b4-45f7-98f2-23c1a8e32884:leadership_role:9. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:53cdf6e9a35daf9ba63df37b6f83579fbc29c895d978ced952a98aba4990fa1d. - Steffen Thomas, PhD: Director, Audit; Compensation; Nominating and Governance. Claim: alpha:claim:company:121f7b6f-a4b4-45f7-98f2-23c1a8e32884:leadership_role:10. Valid from: 2015-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:53cdf6e9a35daf9ba63df37b6f83579fbc29c895d978ced952a98aba4990fa1d. - Christopher Missling: Chief Executive Officer (Principal Executive Officer) and Director. Claim: alpha:claim:company:121f7b6f-a4b4-45f7-98f2-23c1a8e32884:leadership_role:11. Valid from: 2025-11-25. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9f205fe9829a88ea6e12c20b053076954e52cf5c3d530f18f1434f6742abeb8b. - Sandra Boenisch: Principal Financial Officer and Treasurer (Principal Accounting Officer). Claim: alpha:claim:company:121f7b6f-a4b4-45f7-98f2-23c1a8e32884:leadership_role:12. Valid from: 2025-11-25. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ecac7abc032068259c1a0481761468b288f888737c6a2fc45ebcc7844555f828. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Claus van der Velden, PhD; Members Claus van der Velden, PhD (Chair); Jiong Ma, PhD; Steffen Thomas, PhD. Claim: alpha:claim:company:121f7b6f-a4b4-45f7-98f2-23c1a8e32884:committee_record:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2ab0488193823ab5f71d4559aa6cebc6e6da679c85933fbb21b2d2d313c5de88. - Compensation: Chair Claus van der Velden, PhD; Jiong Ma, PhD; Members Claus van der Velden, PhD (Chair); Jiong Ma, PhD (Chair); Steffen Thomas, PhD. Claim: alpha:claim:company:121f7b6f-a4b4-45f7-98f2-23c1a8e32884:committee_record:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2ab0488193823ab5f71d4559aa6cebc6e6da679c85933fbb21b2d2d313c5de88. - Nominating and Governance: Chair Claus van der Velden, PhD; Members Claus van der Velden, PhD (Chair); Jiong Ma, PhD; Steffen Thomas, PhD. Claim: alpha:claim:company:121f7b6f-a4b4-45f7-98f2-23c1a8e32884:committee_record:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2ab0488193823ab5f71d4559aa6cebc6e6da679c85933fbb21b2d2d313c5de88. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - ANAVEX LIFE SCIENCES CORP.. Claim: alpha:claim:company:121f7b6f-a4b4-45f7-98f2-23c1a8e32884:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:15c9b717e438329d7ef37d3e9faa595918b2a3704563aa00e36892ed89b22117. ## Entity Status - Public listing published. Claim: alpha:claim:company:121f7b6f-a4b4-45f7-98f2-23c1a8e32884:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:15c9b717e438329d7ef37d3e9faa595918b2a3704563aa00e36892ed89b22117. ## Published Fact - US. Claim: alpha:claim:company:121f7b6f-a4b4-45f7-98f2-23c1a8e32884:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:15c9b717e438329d7ef37d3e9faa595918b2a3704563aa00e36892ed89b22117. ## Committee Appointment - Claus van der Velden, PhD: chair, Audit. Claim: alpha:claim:company:121f7b6f-a4b4-45f7-98f2-23c1a8e32884:committee_appointment:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2ab0488193823ab5f71d4559aa6cebc6e6da679c85933fbb21b2d2d313c5de88. - Jiong Ma, PhD: member, Audit. Claim: alpha:claim:company:121f7b6f-a4b4-45f7-98f2-23c1a8e32884:committee_appointment:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2ab0488193823ab5f71d4559aa6cebc6e6da679c85933fbb21b2d2d313c5de88. - Steffen Thomas, PhD: member, Audit. Claim: alpha:claim:company:121f7b6f-a4b4-45f7-98f2-23c1a8e32884:committee_appointment:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2ab0488193823ab5f71d4559aa6cebc6e6da679c85933fbb21b2d2d313c5de88. - Claus van der Velden, PhD: chair, Compensation. Claim: alpha:claim:company:121f7b6f-a4b4-45f7-98f2-23c1a8e32884:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2ab0488193823ab5f71d4559aa6cebc6e6da679c85933fbb21b2d2d313c5de88. - Jiong Ma, PhD: chair, Compensation. Claim: alpha:claim:company:121f7b6f-a4b4-45f7-98f2-23c1a8e32884:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2ab0488193823ab5f71d4559aa6cebc6e6da679c85933fbb21b2d2d313c5de88. - Steffen Thomas, PhD: member, Compensation. Claim: alpha:claim:company:121f7b6f-a4b4-45f7-98f2-23c1a8e32884:committee_appointment:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2ab0488193823ab5f71d4559aa6cebc6e6da679c85933fbb21b2d2d313c5de88. - Claus van der Velden, PhD: chair, Nominating and Governance. Claim: alpha:claim:company:121f7b6f-a4b4-45f7-98f2-23c1a8e32884:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2ab0488193823ab5f71d4559aa6cebc6e6da679c85933fbb21b2d2d313c5de88. - Jiong Ma, PhD: member, Nominating and Governance. Claim: alpha:claim:company:121f7b6f-a4b4-45f7-98f2-23c1a8e32884:committee_appointment:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2ab0488193823ab5f71d4559aa6cebc6e6da679c85933fbb21b2d2d313c5de88. - Steffen Thomas, PhD: member, Nominating and Governance. Claim: alpha:claim:company:121f7b6f-a4b4-45f7-98f2-23c1a8e32884:committee_appointment:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2ab0488193823ab5f71d4559aa6cebc6e6da679c85933fbb21b2d2d313c5de88. ## Security Listing - AVXL (NASDAQ). Claim: alpha:claim:company:121f7b6f-a4b4-45f7-98f2-23c1a8e32884:security_listing:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:15c9b717e438329d7ef37d3e9faa595918b2a3704563aa00e36892ed89b22117. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:15c9b717e438329d7ef37d3e9faa595918b2a3704563aa00e36892ed89b22117: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/anavex-life-sciences-corp). - alpha:projection-evidence:document:53cdf6e9a35daf9ba63df37b6f83579fbc29c895d978ced952a98aba4990fa1d: [ANAVEX LIFE SCIENCES CORP. DEF 14A 2025-04-25](https://www.sec.gov/Archives/edgar/data/1314052/000173112225000607/e6511_def14a.htm). - alpha:projection-evidence:document:9f205fe9829a88ea6e12c20b053076954e52cf5c3d530f18f1434f6742abeb8b: [AVXL 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1314052/000173112225001596/e7052_10-k.htm). - alpha:projection-evidence:document:ecac7abc032068259c1a0481761468b288f888737c6a2fc45ebcc7844555f828: [AVXL 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1314052/000173112225001596/e7052_10-k.htm). - alpha:projection-evidence:2ab0488193823ab5f71d4559aa6cebc6e6da679c85933fbb21b2d2d313c5de88: [Audit](https://www.sec.gov/Archives/edgar/data/1314052/000173112225000607/e6511_def14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/anavex-life-sciences-corp) - [Public Markdown](https://registry.alpha.ac/companies/anavex-life-sciences-corp.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/anavex-life-sciences-corp?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/anavex-life-sciences-corp?format=jsonld) - MCP resource: `alpha://companies/anavex-life-sciences-corp` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-20T04:38:05.217361+00:00; recorded 2026-10-20T04:38:05.217361+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.